Oral administration of the contact sensitizer trinitrochlorobenzene: initial sensitization and subsequent appearance of a suppressor population
Our earlier studies have demonstrated that intragastric administration of the hapten trinitrochlorobenzene (TNCB) 2 to 3 weeks prior to attempting sensitization with epidermally applied hapten can abrogate development of systemic contact sensitivity (CS). In this paper, we have examined whether onse...
Saved in:
Published in: | Cellular immunology Vol. 125; no. 2; p. 437 |
---|---|
Main Authors: | , , |
Format: | Journal Article |
Language: | English |
Published: |
Netherlands
01-02-1990
|
Subjects: | |
Online Access: | Get more information |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | Our earlier studies have demonstrated that intragastric administration of the hapten trinitrochlorobenzene (TNCB) 2 to 3 weeks prior to attempting sensitization with epidermally applied hapten can abrogate development of systemic contact sensitivity (CS). In this paper, we have examined whether onset of tolerance following intragastric administration of the hapten is preceded by development of hapten-specific CS. Indeed, CS was found to be present 5 days after feeding TNCB and in most experiments the response decreased significantly by Days 10 to 12. The kinetics of development of CS by the oral and epidermal routes were strikingly similar except that the magnitude of reactivity (up to 5 days) in orally sensitized mice was somewhat less than that of epidermally sensitized mice. With the exception of Peyer's patches (PP), effector cells of CS were recovered from such gut-associated lymphoid tissues as mesenteric lymph nodes (MLN), lamina propria, and lymphocytes that are present in the intraepithelial compartment of the intestinal wall. These cells as well as spleen cells of TNCB-fed mice were able to adoptively transfer CS to naive mice. The capacity of MLN and spleen cells of TNCB-fed mice to confer CS adoptively was abrogated after treating cells with anti-Thy 1.2 and anti-Lyt 1.1 antibodies plus complement thereby identifying them as T lymphocytes. Although CS decreased by 10-12 days after feeding TNCB, the decline was reversed by pretreating mice with cyclophosphamide (CY) 2 days before giving the hapten. Whereas spleen cells from animals fed hapten 5 days earlier transferred CS readily, those from mice fed hapten 12 days earlier did not. However, when 12-day spleen cells were depleted of Lyt 2+ cells their ability to adoptively transfer CS was restored. These observations indicate that feeding TNCB to mice initially produces CS, mediated by Thy 1.2+, Lyt 1.1+ lymphocytes. CS is subsequently down-regulated by activation of Lyt 2+ suppressor cells, precursors of which are sensitive to CY. |
---|---|
AbstractList | Our earlier studies have demonstrated that intragastric administration of the hapten trinitrochlorobenzene (TNCB) 2 to 3 weeks prior to attempting sensitization with epidermally applied hapten can abrogate development of systemic contact sensitivity (CS). In this paper, we have examined whether onset of tolerance following intragastric administration of the hapten is preceded by development of hapten-specific CS. Indeed, CS was found to be present 5 days after feeding TNCB and in most experiments the response decreased significantly by Days 10 to 12. The kinetics of development of CS by the oral and epidermal routes were strikingly similar except that the magnitude of reactivity (up to 5 days) in orally sensitized mice was somewhat less than that of epidermally sensitized mice. With the exception of Peyer's patches (PP), effector cells of CS were recovered from such gut-associated lymphoid tissues as mesenteric lymph nodes (MLN), lamina propria, and lymphocytes that are present in the intraepithelial compartment of the intestinal wall. These cells as well as spleen cells of TNCB-fed mice were able to adoptively transfer CS to naive mice. The capacity of MLN and spleen cells of TNCB-fed mice to confer CS adoptively was abrogated after treating cells with anti-Thy 1.2 and anti-Lyt 1.1 antibodies plus complement thereby identifying them as T lymphocytes. Although CS decreased by 10-12 days after feeding TNCB, the decline was reversed by pretreating mice with cyclophosphamide (CY) 2 days before giving the hapten. Whereas spleen cells from animals fed hapten 5 days earlier transferred CS readily, those from mice fed hapten 12 days earlier did not. However, when 12-day spleen cells were depleted of Lyt 2+ cells their ability to adoptively transfer CS was restored. These observations indicate that feeding TNCB to mice initially produces CS, mediated by Thy 1.2+, Lyt 1.1+ lymphocytes. CS is subsequently down-regulated by activation of Lyt 2+ suppressor cells, precursors of which are sensitive to CY. |
Author | Gautam, S C Battisto, J R Chikkala, N F |
Author_xml | – sequence: 1 givenname: S C surname: Gautam fullname: Gautam, S C organization: Research Institute of the Cleveland Clinic Foundation, Ohio 44106 – sequence: 2 givenname: N F surname: Chikkala fullname: Chikkala, N F – sequence: 3 givenname: J R surname: Battisto fullname: Battisto, J R |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/2137034$$D View this record in MEDLINE/PubMed |
BookMark | eNo9kM1OwzAQhH0oKm3hDUDyEQ4Bx07imBtU_EmVeoFztXHWalBqG9s50JfglWlp4TTSzOy30kzJyDqLhFzk7CZneXXLGKuzWhbqSrFrxZiS2cOITP7tUzKN8YOxPC8UG5Mxz4VkopiQ72WAnkK76WwXU4DUOUudoWmNVDubQCca0cYudVsMNIVdLwWn170LrkG7RYt3dG92O85f84AB29I4NBE_B7SJgvcIAazG_QPYRd4HjNEF6p0f-t-jM3JioI94ftQZeX96fJu_ZIvl8-v8fpFpUcqU5UaVBQhhVC2haapWI8qScxTGQIu1Qc0FtELVomqgkSihllrwtiq5KIzkM3J54Pqh2WC78qHbQPhaHYfhP6IbbBg |
CitedBy_id | crossref_primary_10_1016_j_clim_2008_08_028 crossref_primary_10_1196_annals_1309_053 crossref_primary_10_1111_1523_1747_ep12358502 crossref_primary_10_1016_S0041_008X_03_00091_7 crossref_primary_10_1016_0008_8749_91_90287_L crossref_primary_10_1016_0008_8749_91_90251_6 crossref_primary_10_1111_j_1600_065X_1995_tb00066_x crossref_primary_10_1111_1523_1747_ep12668010 crossref_primary_10_1111_j_0105_2896_2005_00280_x crossref_primary_10_1016_0168_8278_95_80432_3 crossref_primary_10_1111_j_1749_6632_1996_tb21134_x crossref_primary_10_1006_cimm_1997_1119 crossref_primary_10_1016_S0171_2985_11_80107_5 crossref_primary_10_1016_S1286_4579_01_01456_3 crossref_primary_10_1111_j_1600_0625_1993_tb00010_x crossref_primary_10_1111_j_1365_2249_2006_03207_x crossref_primary_10_1016_S0923_2494_99_80003_0 crossref_primary_10_1002_ana_410290608 crossref_primary_10_1002_eji_1830260814 crossref_primary_10_1046_j_1365_2133_2003_05592_x crossref_primary_10_1016_S0167_5699_97_01053_0 crossref_primary_10_1084_jem_188_10_1929 |
ContentType | Journal Article |
DBID | CGR CUY CVF ECM EIF NPM |
DOI | 10.1016/0008-8749(90)90097-B |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: ECM name: MEDLINE url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live sourceTypes: Index Database |
DeliveryMethod | no_fulltext_linktorsrc |
Discipline | Medicine Biology |
ExternalDocumentID | 2137034 |
Genre | Research Support, U.S. Gov't, P.H.S Journal Article |
GrantInformation_xml | – fundername: NIAID NIH HHS grantid: AI-24961 |
GroupedDBID | --- --K --M -~X .55 .GJ .~1 0R~ 1B1 1KJ 1RT 1~. 1~5 29B 3O- 4.4 457 4G. 53G 5GY 5RE 5VS 6J9 7-5 71M 8P~ 9JM AAAJQ AACTN AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AARKO AAXKI AAXUO ABFRF ABGSF ABJNI ABMAC ABUDA ABXDB ACDAQ ACGFO ACGFS ACNCT ACRLP ADBBV ADEZE ADFGL ADMUD ADUVX AEBSH AEFWE AEHWI AEKER AENEX AFJKZ AFKWA AFTJW AFXIZ AGEKW AGHFR AGRDE AGUBO AGYEJ AHHHB AIEXJ AIKHN AITUG AJOXV AKRWK ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC CAG CGR CJTIS COF CS3 CUY CVF DM4 DU5 EBS ECM EFBJH EIF EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HLW HMG HVGLF HX~ HZ~ IHE J1W J5H K-O KOM L7B LG5 LUGTX LX2 LZ5 M41 MO0 N9A NPM O-L O9- OAUVE OHT OZT P-8 P-9 P2P PC. Q38 R2- RIG ROL RPZ SBG SDF SDG SDP SES SEW SIN SPCBC SSI SSU SSZ T5K UNMZH WH7 WUQ X7M XOL XPP Y6R YYP ZGI ZMT ~G- |
ID | FETCH-LOGICAL-c357t-1f954a33f987abb6dcee7522e3ffade8fec23ad39836bab7e7a87c32d65234f72 |
ISSN | 0008-8749 |
IngestDate | Sat Sep 28 08:34:42 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c357t-1f954a33f987abb6dcee7522e3ffade8fec23ad39836bab7e7a87c32d65234f72 |
PMID | 2137034 |
ParticipantIDs | pubmed_primary_2137034 |
PublicationCentury | 1900 |
PublicationDate | 1990-02-01 |
PublicationDateYYYYMMDD | 1990-02-01 |
PublicationDate_xml | – month: 02 year: 1990 text: 1990-02-01 day: 01 |
PublicationDecade | 1990 |
PublicationPlace | Netherlands |
PublicationPlace_xml | – name: Netherlands |
PublicationTitle | Cellular immunology |
PublicationTitleAlternate | Cell Immunol |
PublicationYear | 1990 |
SSID | ssj0011490 |
Score | 1.4757414 |
Snippet | Our earlier studies have demonstrated that intragastric administration of the hapten trinitrochlorobenzene (TNCB) 2 to 3 weeks prior to attempting... |
SourceID | pubmed |
SourceType | Index Database |
StartPage | 437 |
SubjectTerms | Administration, Cutaneous Administration, Oral Animals Antigens, Ly - analysis Cyclophosphamide - pharmacology Dermatitis, Contact - etiology Dermatitis, Contact - immunology Female Intestines - immunology Mice Mice, Inbred C3H Phenotype Picryl Chloride - administration & dosage Picryl Chloride - immunology T-Lymphocytes, Regulatory - immunology |
Title | Oral administration of the contact sensitizer trinitrochlorobenzene: initial sensitization and subsequent appearance of a suppressor population |
URI | https://www.ncbi.nlm.nih.gov/pubmed/2137034 |
Volume | 125 |
hasFullText | |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1NbxMxELWSoqJeEBQqWj7kA5VA1YrN2rv29gYh0EvLoUXiVtlrW1RNk6jZHNo_wV9mxnbWSQEBBy6rlb3xrjxPk5nxvBlCXpXSWcUcFh_kOuOyqjNpjctEbpoyb1RpOLKRj07FyVf5YcRHvd6y914a-6-ShjGQNTJn_0Ha3aIwAPcgc7iC1OH6V3L_jIx7tVYSd5kHgGnpSImcY9J6e3Frrw9aPMBpsW0W-O1TbSe3oPswSoDDnksSnw0L-Sg7qBqff-0LksP2edKBp1nOFzOfVzu9Pph1jcFWzd-hHY9D3ivSUtYi-p_Uog3gPE2R2-G3i8tLNfYG7klKQsaioFgSwUMwpjyaSOXLl8nOK9pYgjYOJUs7bRx40BF2xYpu5aE6zE86P4QfusX28eh0H_9l81pk71d_Ats3u_JyLwYMVB3_4-SdWtxxpk_6YFih7T087o6swNUMfKf4HUue5qB62429rvM38bu2yGZc7Y5D4w2bs4fkQfRI6LsApUekZyfbZDP0KL3ZJvePY_bFY_IdsUXXsUWnjgK2aMQWTdiiv8TWIY3IomvIooAsmpBFE7LwBYomZNGErCfky8fR2fAoiw09soaVos0Gri65YszVUiitKwMWmgAHwDLnlLGgNpqCKcNqySqttLBCSdGwwlRlwbgTxQ7ZmEwn9imhVhoBvo6zhWacayU1FwXXYN6WttaF2CU7YVPPZ6Fqy3nc7b3fTTwjWwmkz8k9BwrBviD9uVm89JL-AT5shj0 |
link.rule.ids | 782 |
linkProvider | EBSCOhost |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Oral+administration+of+the+contact+sensitizer+trinitrochlorobenzene%3A+initial+sensitization+and+subsequent+appearance+of+a+suppressor+population&rft.jtitle=Cellular+immunology&rft.au=Gautam%2C+S+C&rft.au=Chikkala%2C+N+F&rft.au=Battisto%2C+J+R&rft.date=1990-02-01&rft.issn=0008-8749&rft.volume=125&rft.issue=2&rft.spage=437&rft_id=info:doi/10.1016%2F0008-8749%2890%2990097-B&rft_id=info%3Apmid%2F2137034&rft_id=info%3Apmid%2F2137034&rft.externalDocID=2137034 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0008-8749&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0008-8749&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0008-8749&client=summon |